Steven Attia

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Locally Advanced

Metastatic Renal Cell Carcinoma

Acute Lymphoblastic Leukemia

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Brian Andrew Van Tine, Matthew A Ingham, Steven Attia, Christian F Meyer, John D Baird, Esther Brooks-Asplund, Dhiren D'Silva, Ronald Kong, Anthony Mwatha, Kylie O'Keefe, Marla Weetall, Robert Spiegel, Gary K Schwartz
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Scott M Schuetze, Karla V Ballman, Rachel S Heise, Kristen N Ganjoo, Elizabeth J Davis, Suzanne George, Melissa A Burgess, Edwin Choy, Dale R Shepard, Gabriel Tinoco, Angela C Hirbe, Ciara M Kelly, Steven Attia, Hari A Deshpande, Gary K Schwartz, Brittany L Siontis, Richard F Riedel, Margaret von Mehren, Erin Kozlowski, Helen X Chen, Caroline Astbury, Brian P Rubin
A Single Arm Phase 2 Trial of Trametinib in Patients With Locally Advanced or Metastatic Epithelioid Hemangioendothelioma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Brian Andrew Van Tine, Matthew A Ingham, Steven Attia, Christian F Meyer, John D Baird, Esther Brooks-Asplund, Dhiren D'Silva, Ronald Kong, Anthony Mwatha, Kylie O'Keefe, Marla Weetall, Robert Spiegel, Gary K Schwartz
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Scott M Schuetze, Karla V Ballman, Rachel S Heise, Kristen N Ganjoo, Elizabeth J Davis, Suzanne George, Melissa A Burgess, Edwin Choy, Dale R Shepard, Gabriel Tinoco, Angela C Hirbe, Ciara M Kelly, Steven Attia, Hari A Deshpande, Gary K Schwartz, Brittany L Siontis, Richard F Riedel, Margaret von Mehren, Erin Kozlowski, Helen X Chen, Caroline Astbury, Brian P Rubin
A Single Arm Phase 2 Trial of Trametinib in Patients With Locally Advanced or Metastatic Epithelioid Hemangioendothelioma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Brian Andrew Van Tine, Matthew A Ingham, Steven Attia, Christian F Meyer, John D Baird, Esther Brooks-Asplund, Dhiren D'Silva, Ronald Kong, Anthony Mwatha, Kylie O'Keefe, Marla Weetall, Robert Spiegel, Gary K Schwartz
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Scott M Schuetze, Karla V Ballman, Rachel S Heise, Kristen N Ganjoo, Elizabeth J Davis, Suzanne George, Melissa A Burgess, Edwin Choy, Dale R Shepard, Gabriel Tinoco, Angela C Hirbe, Ciara M Kelly, Steven Attia, Hari A Deshpande, Gary K Schwartz, Brittany L Siontis, Richard F Riedel, Margaret von Mehren, Erin Kozlowski, Helen X Chen, Caroline Astbury, Brian P Rubin
A Single Arm Phase 2 Trial of Trametinib in Patients With Locally Advanced or Metastatic Epithelioid Hemangioendothelioma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Brian Andrew Van Tine, Matthew A Ingham, Steven Attia, Christian F Meyer, John D Baird, Esther Brooks-Asplund, Dhiren D'Silva, Ronald Kong, Anthony Mwatha, Kylie O'Keefe, Marla Weetall, Robert Spiegel, Gary K Schwartz
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Scott M Schuetze, Karla V Ballman, Rachel S Heise, Kristen N Ganjoo, Elizabeth J Davis, Suzanne George, Melissa A Burgess, Edwin Choy, Dale R Shepard, Gabriel Tinoco, Angela C Hirbe, Ciara M Kelly, Steven Attia, Hari A Deshpande, Gary K Schwartz, Brittany L Siontis, Richard F Riedel, Margaret von Mehren, Erin Kozlowski, Helen X Chen, Caroline Astbury, Brian P Rubin
A Single Arm Phase 2 Trial of Trametinib in Patients With Locally Advanced or Metastatic Epithelioid Hemangioendothelioma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Matthew A Ingham, Jacob B Allred, Li Chen, Biswasjit Das, Bose S Kochupurakkal, Katherine Gano, Suzanne George, Steven Attia, Melissa A Burgess, Mahesh Seetharam, Sosipatros A Boikos, Nam Q Bui, James L Chen, Julia L Close, Gregory M Cote, Premal H Thaker, Susan Percy Ivy, Sminu Bose, Alan D' Andrea, Adrian Mariño-Enriquez, Geoffrey I Shapiro, Gary K Schwartz
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Benjamin K Wilke, Hillary W Garner, Joseph M Bestic, Lori A Chase, Michael G Heckman, Jennifer J Schoch, Steven Attia
A Pilot Study of Intralesional Injection of Triamcinolone Acetonide for Desmoid Tumors: Two Year Outcomes. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Sebastian Bauer, Robin L Jones, Jean Yves Blay, André B P van Kuilenburg, Suzanne George, Patrick Schöffski, Margaret von Mehren, John R Zalcberg, Yoon-Koo Kang, Albiruni Abdul Razak, Jonathan C Trent, Steven Attia, Axel Le Cesne, Ying Su, Julie Meade, Tao Wang, Matthew L Sherman, Rodrigo Ruiz-Soto, Michael C Heinrich
Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (34) (2022)